Emi A Lutz

6PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 01, 2024
CD8+ T cell priming that is required for curative intratumorally anchored anti-4-1BB immunotherapy is constrained by Tregs.

Joseph R Palmeri, Brianna M Lax, Joshua M Peters

|Aug 29, 2022
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies.

Emi A Lutz, Yash Agarwal, Noor Momin

|Jan 11, 2022
Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity.

Yash Agarwal, Lauren E Milling, Jason Y H Chang

|Jan 11, 2022
Maximizing response to intratumoral immunotherapy in mice by tuning local retention.

Noor Momin, Joseph R Palmeri, Emi A Lutz

|Jun 28, 2019
Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy.

Noor Momin, Naveen K Mehta, Nitasha R Bennett

Pageof 1